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Abstract  
Saccharin is a widely used sweetener especially prescribed for the diabetics. But since its discovery, its use has been a 
matter of controversy due to its tumour promoting abilities in second generations of rats. As a result, saccharin was thought 
to be unfit for human consumption. Later on various studies focused on the possible mechanism of carcinogenic effects of 
saccharin on different animals. Several epidemiological studies were conducted to find out the relation of saccharin with 
cancer promotion. But no significant association was found between saccharin intake and cancer in humans. It was found 
that urinary bladder cancer is a high dose phenomenon and is species specific, which occurs only in rats. Lastly, in 2000, 
saccharin was removed from the list of human carcinogens by National Toxicology Programme, USA and International 
Agency for Research on Cancer (IARC). In this article, an effort has been made to study the historical and toxicological 
aspects of saccharin.   
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INTRODUCTION 
 
  Saccharin (CAS No. 81-07-2) is a non-caloric food additive 
known for its sweetness. Its molecular formula is C7H5NO3S. This 
chemical is one of the most extensively studied and investigated in 
relation to its possible carcinogenic effects. Saccharin is a heat 
stable chemical with a long shelf life and is inexpensive. Because of 
its sweetness, which was glucose free, it was originally thought to be 
used for diabetic patients as an alternate source of sugar. In areas 
with shortage of sugar, it proved to be a boon. Apart from being used 
as a sweetener, saccharin is used for different purposes including as 
an antiseptic, antistatic agent, preservative, nickel plating etc. [1]  
 
Saccharin use remained a controversy due to its carcinogenicity in 
rats. But it attained the ‘generally recognized as safe’ (GRAS) status 
in 1958. In 1970, a positive association was found between 
saccharin and bladder cancer in two generation bioassay in rats. 
Later, in 1973, Hicks et al. [2] wrote a letter in Nature about the 
carcinogenic effect of saccharin in chemical induction of bladder 
cancer. This was followed by a research paper, again by Hicks et al. 
[3] titled “Impurities in saccharin and bladder cancer.” These studies 
again put saccharin in controversy for its possible ability to induce 
urinary bladder neoplasms in rats. 
 
TOXICOLOGICAL STUDIES ON SACCHARIN 
 
 In 1974, Armstrong and Doll [4] reported bladder cancer mortality 
in England in relation to saccharin consumption. Armstrong and Doll 
[5], in an another study in 1975, investigated bladder cancer mortality 
in diabetics in relation to saccharin consumption. They investigated 
the death certificates of 18,733 patients who died from bladder 
cancer with diabetes mellitus. Diabetics were found to consume 
more saccharin than non-diabetics. But this study found no relation 
of diabetes of long duration with increased bladder cancer risk. In 
1977, Culliton [6] wrote an article titled “Cancer society takes pro- 
saccharin stand” thus increasing the saccharin controversy. In 1978, 
many researchers started investigating and writing about the 
possible carcinogenicity of saccharin [7-12]. In 1979, Cohen et al. 
[13] reported saccharin as a potent promoting agent of bladder 
tumours having a short latent period in male Fischer rats. Meneely 
[14] in 1979, wrote on “Saccharin and cancer.” Hooson et al. [15] in 
1980, reported the carcinogenicity of saccharin and ortho-toulene 
sulphonamide (OTS) in rats. This study did not find any tumour 
promoting abilities but reported an increase in the proliferative 
lesions in the rat urinary bladders. Similarly, Nakanishi et al. [16] 
reported the induction of early stage bladder lesions due to saccharin 
with a dose responsive effect in Fischer 344 rats. On the contrary, 
Schmahl and Habs [17] gave a clear chit to saccharin reporting that 
the application of cyclamate and saccharin during pregnancy do not 
pose a risk for any type of cancer risk in sprague-dawley rats. Thus, 
the controversy persisted. 
 
SACCHARIN RESEARCH: THE POSSIBLE MECHANISMS  
 
 Till 1980, many studies had reported for the carcinogenicity of 
saccharin, but at that time, its mechanism was not known. In 1981, 
Kakizoe et al. [18] demonstrated the possible mechanism by which 
saccharin causes its cancer promoting effect. This study reported 
that saccharin, when given continuously, maintained an increased 
agglutinability of isolated bladder epithelial cells of rat, resulting in 
tumour promoting effects. Various animal experiments till then, had 
shown a carcinogenic effect of saccharin on rats. It was proved that 
rats fed on saccharin were more prone to develop bladder tumours if 
they have been exposed to saccharin in-vitro through their mother’s 
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food. There was no evidence of bladder tumour risk in humans 
following in-utero exposure to saccharin. In 1982, Jensen and 
Kamby [19] investigated intra-uterine exposure to saccharin and risk 
of bladder cancer but found no evidence of human bladder cancer 
risk in the first 30-35 years of life in relation to in-vitro saccharin 
exposure. After reports on bladder cancer, Pereira et al. [20] 
reported the tumour promoting ability of saccharin in rat liver. This 
study reported the induction of hyperplastic nodules and 
hepatocellular carcinoma with the administration of sodium salt of 
saccharin in the diet with Di-butyl nitrosamine (DBN). Saccharin 
proved to increase the tumourogenic response of DBN in liver.  
 
 Again in 1983, Renwick and Sims [21] reported the bladder 
distention ability of saccharin in rats. Short term administration of 
high dietary levels of saccharin used in previous two generation 
cancer bioassays, produced functional changes in urinary bladder. 
Higher incidences of tumours were also reported. These reports 
awakened the researchers to find out more about the possible 
mechanisms of tumour induction by saccharin as Kakizoe et al. [18] 
did in 1981. In 1984, Byard and Clayson [22], in two different studies, 
worked on the possible action mechanism of saccharin. Clayson [23] 
suggested that saccharin is associated to bladder cancer due to its 
relation with the integrity of the urothelial permeability barrier in 
Sprague-Dawley rats. It was also suggested that once saccharin 
enters the urothelium, it inhibits certain enzymes, resulting in the 
ultimate effect. To further enhance the study on saccharin, Hasegava 
et al. [24] in the same year investigated the possibility of a mutagen 
being generated as a result of saccharin feeding. No bacterial 
contamination, production of nitrosamines or mutagenic activity was 
found in urine of sodium saccharin fed rats. As to study the effect on 
liver, in line with Pereira et al. [20], no significant changes in liver 
microsomal enzymes (cytochrome p-450, NADPH cytochrome C 
reductase and aniline hydroxylase) were observed following sodium 
saccharin feeding. Agglutination of rat urinary bladder epithelial cells 
by concanavalin A (Con A) had been earlier reported by Kakizoe et 
al. [18]. On the same track, Suzuki et al. [25] in 1984, reported that 
Con A distinguishes between regeneration hyperplasia induced by 
cyclophosphamide (CP) or freezing, followed by sodium saccharin in 
the diet and results in bladder cancer in rats. 
 
 Thus, the reports related to the carcinogenicity of saccharin put a 
mark on the use of saccharin for human consumption. Even, the 
results of studies on rats, hamsters, mice and monkeys for saccharin 
carcinogenicity were positive in the second generation only as 
compared to the control animals. The studies had not reported 
saccharin as a cancer inducer in a single generation. In 1985, 
Council on Scientific Affairs [26], reviewed the safety issues of 
saccharin in relation to human consumption. As available evidences 
indicated no association of saccharin with the induction of bladder 
cancer in humans, the council suggested that saccharin should 
continue to be available as a food additive for human consumption 
although adverse health effects should be monitored. In 1985, many 
studies were conducted to find more on the toxicological aspects of 
saccharin [27-33]. Armstrong [27], in an epidemiological survey in 
1985, failed to find any evidence of an increase in bladder cancer 
risk in diabetics using more saccharin than non-diabetics. At that 
time, the literature available indicated that sodium salt of saccharin is 
non-reactive to DNA and inactive as a gene mutagen in-vitro. The 
recorded genotoxic activity of these salts became apparent only at 
elevated dose levels. Thus, Ashby [28] stressed upon the need to 
evaluate the genotoxicity of potassium, calcium and sodium salts of 
saccharin. 
 Parallel studies in 1985 on effects of saccharin on man were 
going on. In this light, Carlborg [29] concluded that cancer risk at low 
doses of saccharin on man is very small. In 1986, Cohen [34] 
reported that epidemiological studies in human beings have not 
found an increased risk of developing bladder cancer with exposure 
to saccharin.  In an another study, Gaylor et al. [35] estimated the 
upper limit of bladder cancer risk to be between 0.00038 and 0.18 
times the percentage of saccharin in the diet. In 1990, Ellwein and 
Cohen [36] reported that the chemical form of saccharin in the urine 
is unaffected, and there is no evidence for a specific cell receptor for 
the saccharin molecule. Changes in several urinary parameters, 
such as pH, sodium, protein, silicates, volume, and others, appear to 
influence the reaction of the urothelium to sodium saccharin 
administration. Next year, in 1991, Homma et al. [37] indicated no 
demonstrable bladder carcinogenicity of sodium saccharin in 
analbuminaemic rats. Similarly, Okamura 1991 [38] demonstrated 
that sodium saccharin does not promote bladder cancer in male rats 
if fed in AIN-76A diet. Carcinogenic effects were again reviewed by 
Chappel [39] in 1992 showing that saccharin does not increase the 
risk of bladder cancer in humans and laboratory investigations have 
shown that sodium saccharin is not mutagenic and does not bind to 
DNA. Renwick [40] in 1993, demostrated that the toxic effect of 
saccharin is only seen under specific conditions in rats, largely with 
the sodium salt and with a commercial rat diet. The effect is not 
related to the concentration of saccharin in the rat urine or bladder. 
Since then, many other researches were done on saccharin use [41-
45]. In 2000, in the absence of concrete evidence against 
carcinogenicity of saccharin in humans, the National Toxicology 
Program (NTP), USA, removed saccharin from its report on 
carcinogens. Also, the International Agency for Research on Cancer 
(IARC) changed its rating of saccharin from Group 2B, “possibly 
carcinogenic to humans” to Group 3, “not classifiable as to the 
carcinogenicity to humans”.   
 
CONCLUSION 
 
 Since its discovery in 1879, saccharin remained in controversy 
regarding its fitness for human consumption. The studies on rats 
have demonstrated its ability to produce bladder cancer in two 
generation biassays. Now, this fact has been accepted worldwide 
that saccharin is cancerous in rats in high doses and saccharin does 
not pose a risk of cancer in human beings and can be continued to 
be used as a food additive.  
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